Sphingolipid S1P: Potential new target for schizophrenia treatment
Sphingolipid S1P is reduced in brain white matter of people with schizophrenia, making S1P receptors a good target for new treatments.
Apr 29
Sphingolipid S1P is reduced in brain white matter of people with schizophrenia, making S1P receptors a good target for new treatments.
Apr 23
Artificial gravity protects the immune system of mice in space
Mice who experienced artificial gravity on the ISS suffered less damage to their immune system (thymus) than weightless mice did.
Mar 9
Tape and vermilion: ingredients for mapping artifact origins
Vermilion samples taken from ancient artifacts with sulfur-free tape can tell us about trade patterns 3000 years ago.
Jan 29
Are you “at risk” of being a habitual coffee drinker?
Several single nucleotide polymorphisms (SNPs) are related to dietary habits, including coffee, tea, tofu, and yogurt consumption.
Oct 29
Schizophrenia biomarker (hydrogen sulfide) in human hair
Not only is hydrogen sulfide a good biomarker for schizophrenia, it’s also the culprit and a new starting point for drug discovery.
Oct 10
Brain tissue kept alive for weeks with new microfluidic device
A new microfluidic device can keep tissue cultures functional for weeks on an artificial membrane
RIKEN at a Glance
30-day trend
- February 15, 2022
Green hydrogen production for fuel cells and fertilizers - December 27, 2015
Black smokers and electroecosystems - November 26, 2020
Bacterial drug resistance studied by robotic E. coli evolution - October 2, 2024
Stem cell exhaustion and proliferation: An aging fly’s tale - January 13, 2022
How does gravity affect antimatter?
Topics
